tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FHTX Stock Latest News

Foghorn Therapeutics Unveils Strategic Plans to Investors
Company AnnouncementsFoghorn Therapeutics Unveils Strategic Plans to Investors
2M ago
8K
FHTX
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
PremiumPress Releases
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June
2M ago
FHTX
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
PremiumPress Releases
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
2M ago
FHTX
Foghorn Therapeutics prices 12.7M shares at $5.51 in registered direct offering
PremiumThe Fly
Foghorn Therapeutics prices 12.7M shares at $5.51 in registered direct offering
2M ago
FHTX
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
PremiumPress Releases
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
2M ago
FHTX
Foghorn Therapeutics provides update on programs, upcoming milestones
PremiumThe FlyFoghorn Therapeutics provides update on programs, upcoming milestones
2M ago
FHTX
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
PremiumPress Releases
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
2M ago
FHTX
Foghorn Therapeutics reports Q1 EPS (59c), consensus (63c)
PremiumThe Fly
Foghorn Therapeutics reports Q1 EPS (59c), consensus (63c)
2M ago
FHTX
Foghorn Therapeutics, Inc. (FHTX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Foghorn Therapeutics, Inc. (FHTX) Q1 Earnings Cheat Sheet
3M ago
FHTX
Foghorn Therapeutics Appoints Kristian Humer as New CFO
PremiumCompany Announcements
Foghorn Therapeutics Appoints Kristian Humer as New CFO
3M ago
8K
FHTX
Foghorn Therapeutics appoints Humer as Chief Financial Officer
PremiumThe Fly
Foghorn Therapeutics appoints Humer as Chief Financial Officer
3M ago
FHTX
VRDN
Foghorn Therapeutics Unveils Cancer Research Breakthroughs
PremiumCompany Announcements
Foghorn Therapeutics Unveils Cancer Research Breakthroughs
3M ago
8K
FHTX
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
PremiumPress ReleasesFoghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
3M ago
FHTX
Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
PremiumPress Releases
Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
4M ago
FHTX
Foghorn to Host Conference Call and Webcast on Pipeline of Potential First-in-Class Medicines in Conjunction with the 2024 AACR Annual Meeting
PremiumPress Releases
Foghorn to Host Conference Call and Webcast on Pipeline of Potential First-in-Class Medicines in Conjunction with the 2024 AACR Annual Meeting
4M ago
FHTX
Foghorn Therapeutics Unveils New Investor Presentation
PremiumCompany Announcements
Foghorn Therapeutics Unveils New Investor Presentation
4M ago
8K
FHTX
Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook
PremiumPress Releases
Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook
4M ago
FHTX
Foghorn Therapeutics expects cash runway into first half of 2026
PremiumThe Fly
Foghorn Therapeutics expects cash runway into first half of 2026
4M ago
FHTX
Foghorn Therapeutics reports FY23 EPS ($2.34), consensus ($2.48)
PremiumThe Fly
Foghorn Therapeutics reports FY23 EPS ($2.34), consensus ($2.48)
4M ago
FHTX
Foghorn Therapeutics, Eli Lilly to present new preclinical data at AACR
PremiumThe FlyFoghorn Therapeutics, Eli Lilly to present new preclinical data at AACR
5M ago
LLY
FHTX
Foghorn Therapeutics to Present New Preclinical Data at 2024 AACR Annual Meeting, Reflecting Advances with Multiple Potential First-in-Class Medicines, including the Selective Inhibitor of BRM, FHD-909
PremiumPress Releases
Foghorn Therapeutics to Present New Preclinical Data at 2024 AACR Annual Meeting, Reflecting Advances with Multiple Potential First-in-Class Medicines, including the Selective Inhibitor of BRM, FHD-909
5M ago
FHTX
Is FHTX a Buy, Before Earnings?
PremiumPre-Earnings
Is FHTX a Buy, Before Earnings?
5M ago
FHTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >